Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions

• Glioblastoma Mutliforme

Interventions

• RADIATION: IMRT Technique
• RADIATION: IMRT and accelerated hypofractionation technique
• RADIATION: neo-adjuvant TMZ followed by accelerated hypofractionated EBRT
• DRUG: Temozolomide and Accelerated Hypofractionation RT

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre